Cell Therapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cell Therapy stocks.

Cell Therapy Stocks Recent News

Date Stock Title
May 16 CELU Celularity GAAP EPS of -$0.48, revenue of $5.9M
May 16 CELU Celularity Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 16 TCRT Alaunos Therapeutics, Inc. (TCRT) CEO Kevin Boyle on Q1 2022 Results - Earnings Call Transcript
May 16 TIL Instil Bio Non-GAAP EPS of -$0.36
May 16 TCRT Alaunos Therapeutics GAAP EPS of -$0.05 beats by $0.02
May 16 TCRT Alaunos Therapeutics Reports First Quarter 2022 Financial Results
May 16 CGEM Cullinan Oncology GAAP EPS of -$0.27 beats by $0.28
May 16 TIL Instil Bio Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 16 CGEM Cullinan Oncology Provides Corporate Update and Reports First Quarter 2022 Financial Results
May 16 CELU 110 Biggest Movers From Friday
May 16 TCRT Earnings Scheduled For May 16, 2022
May 13 TCRT Alaunos Therapeutics Q1 2022 Earnings Preview
May 12 BLCM Bellicum Pharmaceuticals GAAP EPS of -$0.25 beats by $0.42
May 12 BLCM Bellicum Reports First Quarter 2022 Financial Results and Provides Operational Update
May 12 CRBU Caribou extends gains as SVB Leerink raises target after early data for CAR-T asset
May 12 TCRT Insiders who placed huge bets on Alaunos Therapeutics, Inc. (NASDAQ:TCRT) earlier this year would be disappointed with the 27% drop
May 12 CRBU Caribou's Lymphoma Candidate Shows 100% Response Rate In Early-Stage Study
May 12 CGEM Why Are Cullinan Oncology Shares Rising Today?
May 12 CRBU Caribou Biosciences rises 27% on early-stage CAR-T therapy data for non-Hodgkin lymphoma
May 12 CRBU Caribou Biosciences Announces Positive Initial Data for CB-010 Anti-CD19 Allogeneic CAR-T Cell Therapy

Cell therapy (also called cellular therapy or cytotherapy) is therapy in which cellular material is injected into a patient; this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
Cell therapy originated in the nineteenth century when scientists experimented by injecting animal material in an attempt to prevent and treat illness. Although such attempts produced no positive benefit, further research found in the mid twentieth century that human cells could be used to help prevent the human body rejecting transplanted organs, leading in time to successful bone marrow transplantation.Today two distinct categories of cell therapy are recognized.The first category is cell therapy in mainstream medicine. This is the subject of intense research and the basis of potential therapeutic benefit. Such research can be controversial when it involves human embryonic material.
The second category is in alternative medicine, and perpetuates the practice of injecting animal materials in an attempt to cure disease. This practice, according to the American Cancer Society, is not backed by any medical evidence of effectiveness, and can have deadly consequences.

More about Cell Therapy
Browse All Tags